Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
Bank: total debt and net cash aren't shown — a bank's cash is mostly its customers' deposits. How we decide
Share prices are the last trade on IEX each day, not the official closing price, and are a day behind. Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
INHIBRX BIOSCIENCES, INC. (INBX), most recent 12 months reported: revenue $1.3M, net loss $138.18M, free cash flow -$131.9M. Latest balance sheet on file: liquid cash $133.34M, total debt $176.28M, net cash -$42.94M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): DYADIC INTERNATIONAL INC · Aligos Therapeutics, Inc. · Humacyte, Inc. · SCINAI IMMUNOTHERAPEUTICS LTD. · Pluri Inc. · ProKidney Corp. · ImageneBio, Inc. · CARDIFF ONCOLOGY, INC.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Share prices are the last trade on IEX, not the official closing price, and are a day behind. Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.